ArticleVeterinary and animal science2026
Impact of chronic dietary aflatoxin B1 intake on rumen fermentation, hepatic health, oxidative stress, inflammation, and glucose-lipid metabolism in fat-tailed ewes.
Article in Veterinary and animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic dietary exposure to aflatoxin B₁ (AFB₁) is a major threat to ruminant health, but its integrated effects on rumen fermentation, hepatic function, inflammatory-oxidative status, and glucose-lipid metabolism in fat-tailed sheep remain insufficiently characterized. This study evaluated the effects of high-level chronic AFB₁ exposure in twenty non-pregnant, non-lactating multiparous Ghezel ewes assigned to either a control diet or the same basal diet supplemented with AFB₁-contaminated rice culture providing 500 µg AFB₁/kg dry matter for 40 d. Individual dry matter intake was not measured; however, all animals consumed the full daily ration, ensuring uniform nutrient intake. AFB₁ reduced ruminal total volatile fatty acid concentration by approximately 16% (P = 0.011), with lower acetate (P = 0.014) and propionate (P = 0.017), and increased ruminal ammonia nitrogen (P = 0.018) and lipopolysaccharide (P = 0.009). Plasma activities of aspartate aminotransferase, γ-glutamyl transferase, and glutamate dehydrogenase increased approximately 2.2-, 2.9-, and 2.8-fold, respectively (all P < 0.001), while albumin and total protein decreased. AFB₁ increased TNF-α, IL-6, IL-1β, nitric oxide, and protein carbonyls, and decreased IL-10, IFN-γ, glutathione, superoxide dismutase, and catalase. During intravenous glucose tolerance testing, AFB₁-exposed ewes had lower basal glucose, higher peak glucose, greater incremental glucose area under the curve, prolonged glucose half-life, higher basal non-esterified fatty acids, and attenuated NEFA suppression. These findings indicate that chronic high-level AFB₁ exposure disrupts coordinated rumen-liver-immune-metabolic function and reduces glucose-lipid metabolic flexibility in fat-tailed ewes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.